Shahin Gharakhanian MD leads Program Committee for 3rd New England Life Sciences Panorama meeting at the Genzyme Center, Cambridge MA, USA ● Meeting Report
April 28, 2016
2016 NE Life Sciences Panorama Meeting 15 March SUMMARY
April 28, 2016
2016 NE Life Sciences Panorama Meeting 15 March SUMMARY
March 14, 2016
02.18.2016 FINAL PROGRAM Annual LS Panorama
November 27, 2015
Methodological challenges in the Clinical Development of HIV Therapeutic Vaccines. Infection with Human Immunodeficiency Virus (HIV) is a chronic clinical state where discrete, viral replication and homeostatic proliferation of infected memory T cells maintain HIV reservoirs. The medical management of HIV is regarded as a major R&D achievement and...
August 9, 2015
18-20 July 2015, Vancouver, Canada.
June 3, 2015
http://www.hiv-reservoir.net/
March 16, 2015
FACCNE LIFE SCIENCES EVENT Cambridge 18MAR2015
November 10, 2014
BIONOR PHARMA is a leading vaccine company searching for breakthrough treatments for HIV and other lethal viruses [ www.bionorpharma.com ].
September 23, 2014
VAC-3S vaccine, a novel approach to the therapeutic management of HIV Infection. Overview of phase I and phase II clinical vaccine development programs. R Ho Tsong Fang, O Launay, C Katlama, J Crouzet, B Autran, V Vieillard, P Debré, S Gharakhanian 2014.09 VAC-3S J Vaccines Vaccin 2014.55
April 6, 2014
The talk titled “New Initiatives in Academic Commercialization” highlights the University of Pennsylvania – UPenn – UPStart Program and the collaboration with NovoBioPharma a firm co-founded by Shahin Gharakhanian MD Consulting LLC. This is a new collaboration set up to provide innovative business and science solutions for academia-based early...
December 2, 2013
FINAL_InnaVirVax_VAC3S_WorldAIDS DayDec2013